KU Leuven
Mariam Bayoumi is a Research Manager and Postdoctoral Researcher at KU Leuven since April 2024, also holding Research Manager positions at SynEry and ArTCell, both European research consortia focused on innovative biomedical solutions. SynEry aims to develop a scalable artificial blood substitute, while ArTCell is dedicated to creating artificial T cells for anti-tumor therapies, both supported by funding from the Horizon Europe programme. Mariam has been an Assistant Lecturer at Mansoura University since 2011 and previously served as a Scientist at Aelin Therapeutics, a Postdoctoral Researcher at VIB, and a Research Associate at the VIB-KU Leuven Center for Brain & Disease Research. Education includes a PhD in Biophysics from KU Leuven and a Master’s Degree in Medical Physics from Mansoura University.
This person is not in the org chart
This person is not in any offices
KU Leuven
3 followers
Founded in 1425, the multidisciplinary and research-driven University of Leuven (KU Leuven) has been a centre of learning for almost six centuries. Situated in Belgium, in the heart of Western Europe, KU Leuven has been a centre of learning for nearly six centuries. Today, it is Belgium's largest university and, founded in 1425, one of theoldest and most renowned universities in Europe. As a leading European research university and co-founder of the League of European Research Universities (LERU), KU Leuven offers a wide variety of international master’s programmes, all supported by high-quality, innovative, interdisciplinary research. Since its founding, KU Leuven has been based in the city that shares its name. Leuven is a pleasant, safe and bustling student town, where centuries-rich history meets cutting-edge science. The university also offers degree programmes at campuses in 11 Belgian cities, including Brussels, Ghent and Antwerp.